Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20133
20162
20192
20201
20212
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated2
Unknown status2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital3
Asan Medical Center2
Gilead Sciences2
BeOne Medicines1
Boryung Pharmaceutical Co., Ltd1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Kosin University Gospel Hospital1
Loxo Oncology, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia15
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular11
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Mantle-Cell7
Lymphoma, Non-Hodgkin7
Lymphoma, B-Cell4
Burkitt Lymphoma3
Leukemia3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.